Genedrive (GDR) RNS Announcements

Add to Alert list
Date Time Source Announcement
28 May 2020 11:00 AM
RNS
Price Monitoring Extension
27 May 2020 11:35 AM
RNS
Result of General Meeting
27 May 2020 08:15 AM
RNS
Holding(s) in Company
26 May 2020 11:58 AM
RNS
Holding(s) in Company
26 May 2020 09:30 AM
RNS
Holding(s) in Company
22 May 2020 11:05 AM
RNS
Second Price Monitoring Extn
22 May 2020 11:00 AM
RNS
Price Monitoring Extension
22 May 2020 09:05 AM
RNS
Second Price Monitoring Extn
22 May 2020 09:00 AM
RNS
Price Monitoring Extension
22 May 2020 07:00 AM
RNS
Genedrive 96 SARS-CoV-2 Kit receives CE-IVD Mark
21 May 2020 09:36 AM
RNS
Holding(s) in Company
20 May 2020 03:38 PM
RNS
Holding(s) in Company
13 May 2020 10:26 AM
RNS
Holding(s) in Company
12 May 2020 07:00 AM
RNS
Results of Broker Option
07 May 2020 05:25 PM
RNS
Holding(s) in Company
07 May 2020 04:58 PM
RNS
Posting of shareholder circular
07 May 2020 11:05 AM
RNS
Second Price Monitoring Extn
07 May 2020 11:00 AM
RNS
Price Monitoring Extension
05 May 2020 06:24 PM
RNS
Result of Placing
05 May 2020 09:00 AM
RNS
Price Monitoring Extension
05 May 2020 08:50 AM
RNS
Proposed Placing and Broker Option
04 May 2020 05:00 PM
RNS
WHO Prequalification for Genedrive HCV-ID test
04 May 2020 02:05 PM
RNS
Second Price Monitoring Extn
04 May 2020 02:00 PM
RNS
Price Monitoring Extension
01 May 2020 02:05 PM
RNS
Second Price Monitoring Extn
01 May 2020 02:01 PM
RNS
Price Monitoring Extension
01 May 2020 07:00 AM
RNS
Manufacturing milestones met for SARS-CoV-2 test
29 Apr 2020 09:06 AM
RNS
Second Price Monitoring Extn
29 Apr 2020 09:00 AM
RNS
Price Monitoring Extension
28 Apr 2020 04:42 PM
RNS
Second Price Monitoring Extn
28 Apr 2020 04:35 PM
RNS
Price Monitoring Extension
28 Apr 2020 02:05 PM
RNS
Second Price Monitoring Extn
28 Apr 2020 02:00 PM
RNS
Price Monitoring Extension
27 Apr 2020 09:00 AM
RNS
Price Monitoring Extension
24 Apr 2020 03:30 PM
RNS
Holding(s) in Company
24 Apr 2020 07:00 AM
RNS
Distribution agreement for AIHL test
22 Apr 2020 07:00 AM
RNS
Appointment of Joint Broker
21 Apr 2020 04:41 PM
RNS
Second Price Monitoring Extn
21 Apr 2020 04:36 PM
RNS
Price Monitoring Extension
21 Apr 2020 02:52 PM
RNS
Holding(s) in Company
20 Apr 2020 09:05 AM
RNS
Second Price Monitoring Extn
20 Apr 2020 09:00 AM
RNS
Price Monitoring Extension
20 Apr 2020 07:00 AM
RNS
Cytiva collaboration on Coronavirus PCR Test
17 Apr 2020 02:06 PM
RNS
Second Price Monitoring Extn
17 Apr 2020 02:01 PM
RNS
Price Monitoring Extension
16 Apr 2020 02:53 PM
RNS
Holding(s) in Company
15 Apr 2020 04:41 PM
RNS
Second Price Monitoring Extn
15 Apr 2020 04:36 PM
RNS
Price Monitoring Extension
15 Apr 2020 02:05 PM
RNS
Second Price Monitoring Extn
15 Apr 2020 02:00 PM
RNS
Price Monitoring Extension

Genedrive plc is a medical equipment company based in Manchester, UK that develops and sells point-of-care molecular diagnostic platforms. Their products are used in healthcare settings, particularly in emergency medicine, for patient stratification and disease detection. Genedrive's goal is to improve clinical outcomes with easy-to-use tests. 

 Genedrive's major products include:
Genedrive CYP2C19 ID Kit: A rapid test that establishes metaboliser status in time-critical settings
Genedrive MT-RNR1 ID Kit: The world's first point-of-care genetic test to reduce the risk of aminoglycoside induced hearing loss

Genedrive was founded on contract research services for pharmaceutical and biotech companies, and was originally named Epistem Holdings Inc. when it was floated on the London AIM market in 2007. The company was renamed genedrive plc in 2016 to reflect its new focus on molecular diagnostics, and divested its contract research services divisions in 2018.

GDR share price launched at 129p in 2007. 

UK 100

Latest directors dealings